These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 29794482)
21. The impact of tonsillectomy combined with steroid pulse therapy in patients with advanced IgA nephropathy and impaired renal function. Kumon S; Moriyama T; Kamiyama T; Karasawa K; Nitta K Clin Exp Nephrol; 2020 Apr; 24(4):295-306. PubMed ID: 31845064 [TBL] [Abstract][Full Text] [Related]
22. The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial. Yang D; He L; Peng X; Liu H; Peng Y; Yuan S; Liu Y; Chen X; Liu F; Liu C Ren Fail; 2016; 38(2):242-8. PubMed ID: 26727697 [TBL] [Abstract][Full Text] [Related]
24. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria. Kawaguchi T; Ieiri N; Yamazaki S; Hayashino Y; Gillespie B; Miyazaki M; Taguma Y; Fukuhara S; Hotta O Nephrology (Carlton); 2010 Feb; 15(1):116-23. PubMed ID: 20377779 [TBL] [Abstract][Full Text] [Related]
25. Impact of tonsillectomy combined with steroid pulse therapy on immunoglobulin A nephropathy depending on histological classification: a multicenter study. Miyamoto T; Nishino T; Nakata T; Sato Y; Komatsu H; Uramatsu T; Ishimatsu N; Ishida K; Serino R; Otsuji Y; Miyazaki M; Tomo T; Tamura M; Fujimoto S Clin Exp Nephrol; 2016 Feb; 20(1):50-7. PubMed ID: 26055039 [TBL] [Abstract][Full Text] [Related]
26. Absence of mesangial C1q deposition is associated with resolution of proteinuria and hematuria after tonsillectomy plus steroid pulse therapy for immunoglobulin a nephropathy. Nishiwaki H; Hasegawa T; Nagayama Y; Kaneshima N; Takayasu M; Hirose M; Komukai D; Inoue Y; Koiwa F; Yoshimura A Nephron; 2015; 130(1):1-7. PubMed ID: 25896237 [TBL] [Abstract][Full Text] [Related]
27. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine. Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884 [TBL] [Abstract][Full Text] [Related]
28. Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Ochi A; Moriyama T; Takei T; Uchida K; Nitta K Int Urol Nephrol; 2013 Apr; 45(2):469-76. PubMed ID: 22833253 [TBL] [Abstract][Full Text] [Related]
29. Tonsillectomy combined with steroid pulse therapy induces clinical remission of IgA nephropathy. Komatsu H; Fujimoto S Adv Otorhinolaryngol; 2011; 72():57-9. PubMed ID: 21865690 [TBL] [Abstract][Full Text] [Related]
30. Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial. Suehiro T; Tsuruya K; Yoshida H; Tsujikawa H; Yamada S; Tanaka S; Tsuchimoto A; Eriguchi M; Fujisaki K; Torisu K; Nakano T; Kitazono T Kidney Blood Press Res; 2021; 46(2):173-184. PubMed ID: 33677450 [TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy]. Sugawara K; Takeda K; Nakai K; Takahashi N; Adachi T; Fukuda T; Miura S Nihon Jinzo Gakkai Shi; 2008; 50(8):1017-23. PubMed ID: 19172803 [TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive agents for treating IgA nephropathy. Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319 [TBL] [Abstract][Full Text] [Related]
33. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Hotta O; Miyazaki M; Furuta T; Tomioka S; Chiba S; Horigome I; Abe K; Taguma Y Am J Kidney Dis; 2001 Oct; 38(4):736-43. PubMed ID: 11576876 [TBL] [Abstract][Full Text] [Related]
34. Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study. Hotta O; Taguma Y; Kurosawa K; Sudo K; Suzuki K; Horigome I Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):967-73. PubMed ID: 8255008 [TBL] [Abstract][Full Text] [Related]
35. A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report. Miyazaki M; Hotta O; Komatsuda A; Nakai S; Shoji T; Yasunaga C; Taguma Y; Contrib Nephrol; 2007; 157():94-8. PubMed ID: 17495443 [TBL] [Abstract][Full Text] [Related]
36. Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathy. Yamamoto Y; Hiki Y; Nakai S; Yamamoto K; Takahashi K; Koide S; Murakami K; Tomita M; Hasegawa M; Kawashima S; Sugiyama S; Yuzawa Y Clin Exp Nephrol; 2013 Apr; 17(2):218-24. PubMed ID: 22926695 [TBL] [Abstract][Full Text] [Related]
37. Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function. Kaneko T; Hirama A; Ueda K; Fujino T; Utsumi K; Iino Y; Katayama Y Clin Exp Nephrol; 2011 Feb; 15(1):73-8. PubMed ID: 20972695 [TBL] [Abstract][Full Text] [Related]
38. Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy. Murakoshi M; Gohda T; Sonoda Y; Suzuki H; Tomino Y; Horikoshi S; Suzuki Y Clin Exp Nephrol; 2017 Dec; 21(6):1068-1074. PubMed ID: 28389814 [TBL] [Abstract][Full Text] [Related]
39. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy. Yang Y; Ohta K; Shimizu M; Nakai A; Kasahara Y; Yachie A; Koizumi S Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643 [TBL] [Abstract][Full Text] [Related]
40. Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis. Mori-Takeyama U; Minatoguchi S; Murata I; Fujiwara H; Ozaki Y; Ohno M; Oda H; Ohashi H Clin Exp Nephrol; 2008 Feb; 12(1):33-40. PubMed ID: 18175062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]